prednisolone has been researched along with African Lymphoma in 48 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
"Both oral and intravenous acyclovir administration for seven days in the early stages of infectious mononucleosis caused an inhibition of oropharyngeal Epstein-Barr virus (EBV) replication." | 6.16 | Management of Epstein-Barr virus infections. ( Andersson, J; Ernberg, I, 1988) |
"Fourteen patients (less than or equal to 35 years of age) with intra-abdominal undifferentiated lymphomas, without evidence of disease elsewhere, were treated by surgical resection and six cycles of combination chemotherapy which included cyclophosphamide, vincristine, doxorubicin, prednisone, and 42-hour methotrexate infusion with leucovorin rescue." | 3.67 | Surgical resection and limited chemotherapy for abdominal undifferentiated lymphomas. ( Edwards, BK; Janus, C; Magrath, IT; Sariban, E, 1984) |
"In a prior study, primary resistant acute lymphoblastic leukemia (RES-ALL) was observed in 11 of 176 (6%) adult patients treated with a four drug regimen (IVAP), its incidence being higher in T-cell or Philadelphia (Ph) chromosome/BCR-ABL rearrangement positive ALL cases with a blast cell count >25x10(9)/L (RES-ALL rate 19%, p=0." | 2.69 | Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinic ( Barbui, T; Bassan, R; Casula, P; Corneo, G; Coser, P; Fabris, P; Izzi, T; Lambertenghi-Deliliers, G; Lerede, T; Morandi, S; Pogliani, E; Rossi, G; Vespignani, M, 1999) |
"Even though acute lymphoblastic leukemia (ALL) responds well to chemotherapy, relapse remains the major problem." | 2.41 | Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. ( Botsonis, A; Moschovi, M; Papadopoulou, AL; Tsangaris, GT; Tzortzatou-Stathopoulou, F, 2001) |
"Burkitt Lymphoma is the fastest growing tumor in human and the commonest of the childhood malignancies." | 1.51 | Generalized lymphadenopathy: an unusual presentation of burkitt lymphoma in a Nigerian child: a case report. ( Chukwu, BF; Emodi, IJ; Ezenwosu, OU; Ikefuna, AN; Okafor, OC, 2019) |
"Histopathological subtypes consist of Burkitt's lymphoma (BL) in 32 (43." | 1.48 | Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan. ( Anwar, S; Faizan, M; Khan, S, 2018) |
"We herein report a rare case of Burkitt lymphoma (BL) preceded by autoimmune hemolytic anemia (AIHA) caused by autoantibodies against D antigen." | 1.43 | Burkitt Lymphoma Preceded by Autoimmune Hemolytic Anemia due to Anti-D Antibody. ( Chinen, Y; Horiike, S; Kobayashi, T; Kuroda, J; Maegawa, S; Matsumoto, Y; Matsumura-Kimoto, Y; Mizuno, Y; Mizutani, S; Nagoshi, H; Shimura, Y; Sumida, Y; Takimoto, T; Tanba, K; Taniwaki, M; Tatekawa, S; Tsukamoto, T; Yamamoto-Sugitani, M, 2016) |
"BACKGROUND AND PURPOSE Endemic Burkitt's lymphoma (eBL) remains the prevalent form of paediatric cancer in tropical Africa with subtle pathological differences." | 1.37 | Prognostic significance of biochemical markers in African Burkitt's lymphoma. ( Arthur, FK; Osei-Akoto, A; Owusu, L; Rettig, T; Yeboah, FA, 2011) |
"To describe an unusual case of Burkitt lymphoma manifesting as acute proptosis and simulating orbital inflammatory disease." | 1.30 | Burkitt lymphoma manifesting as acute proptosis. ( Au Eong, KG; Choo, CT, 1997) |
" A moderate to high dosage of corticosteroids suppressed the development of new skin lesions, but relapses occurred when these systemic corticosteroids were tapered." | 1.30 | Epstein-Barr virus-associated lymphoproliferative skin lesion with recurrent necrotic papulovesicles of the face. ( Jung, DY; Kim, JW; Lee, SK; Lee, WW, 1999) |
" This finding may serve to guide the selection of dexamethasone dosage in the treatment of ALL." | 1.29 | Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. ( Campana, D; Coustan-Smith, E; Evans, WE; Ito, C; Mahmoud, H; McNinch, L; Pui, CH, 1996) |
"A 32-year-old woman was treated for Burkitt's lymphoma diagnosed during the 22nd week of pregnancy." | 1.26 | Normal infant after combination chemotherapy including teniposide for Burkitt's lymphoma in pregnancy. ( Funnell, CF; Hope, DM; Humphrey, DC; Lowenthal, RM; Stewart, IG, 1982) |
"Fifty-four Americans with Burkitt's lymphoma were treated with two sequential combined treatment regimens that incorporated therapeutic approaches from clinical trials in Africa." | 1.26 | Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. ( Ziegler, JL, 1977) |
"One cell line derived from Burkitt's lymphoma was refractory to lethal effects even with pharmacological doses of steroid." | 1.25 | Cytoplasmic receptor levels and glucocorticoid response in human lymphoblastoid cell lines. ( Bird, CC; Currie, AR; Evans, J; Robertson, AM; Steel, CM; Waddell, AW, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (35.42) | 18.7374 |
1990's | 13 (27.08) | 18.2507 |
2000's | 11 (22.92) | 29.6817 |
2010's | 6 (12.50) | 24.3611 |
2020's | 1 (2.08) | 2.80 |
Authors | Studies |
---|---|
Ezenwosu, OU | 1 |
Chukwu, BF | 1 |
Okafor, OC | 1 |
Ikefuna, AN | 1 |
Emodi, IJ | 1 |
Stang, A | 1 |
Schwärzler, P | 1 |
Schmidtke, S | 1 |
Tolosa, E | 1 |
Kobbe, R | 1 |
Hussain, S | 1 |
Hallam, S | 1 |
Beltran, L | 1 |
Haroon, A | 1 |
Majumdar, K | 1 |
Shamash, J | 1 |
Sivapackianathan, R | 1 |
Drake, W | 1 |
Faizan, M | 1 |
Anwar, S | 1 |
Khan, S | 1 |
Mizuno, Y | 1 |
Shimura, Y | 1 |
Horiike, S | 1 |
Takimoto, T | 1 |
Maegawa, S | 1 |
Tanba, K | 1 |
Matsumura-Kimoto, Y | 1 |
Sumida, Y | 1 |
Tatekawa, S | 1 |
Tsukamoto, T | 1 |
Chinen, Y | 1 |
Mizutani, S | 1 |
Nagoshi, H | 1 |
Yamamoto-Sugitani, M | 1 |
Matsumoto, Y | 1 |
Kobayashi, T | 1 |
Kuroda, J | 1 |
Taniwaki, M | 1 |
Tauro, S | 1 |
Cochrane, L | 1 |
Lauritzsen, GF | 1 |
Baker, L | 1 |
Delabie, J | 1 |
Roberts, C | 1 |
Mahendra, P | 1 |
Holte, H | 1 |
Arthur, FK | 1 |
Owusu, L | 1 |
Yeboah, FA | 1 |
Rettig, T | 1 |
Osei-Akoto, A | 1 |
Mottl, H | 1 |
Bajciova, V | 1 |
Nemec, J | 1 |
Al Shemmari, S | 1 |
Al Awadi, S | 1 |
Gupta, M | 1 |
Kumar, A | 1 |
Dabadghao, S | 1 |
Mantzios, G | 1 |
Tsirigotis, P | 1 |
Veliou, F | 1 |
Boutsikakis, I | 1 |
Petraki, L | 1 |
Kolovos, J | 1 |
Papageorgiou, S | 1 |
Robos, Y | 1 |
Bariakh, EA | 1 |
Zvonkov, EE | 1 |
Kremenetskaia, AM | 1 |
Kravchenko, SK | 1 |
Magomedova, AU | 1 |
Obukhova, TN | 1 |
Samoĭlova, RS | 1 |
Vorob'ev, IA | 1 |
Kaplanskaia, IB | 1 |
Moiseeva, TN | 1 |
Zybunova, EE | 1 |
Lorie, IuIu | 1 |
Chernova, NG | 1 |
Mar'in, DS | 1 |
Egorova, EK | 1 |
Krasil'nikova, BB | 1 |
Gabeeva, NG | 1 |
Vorob'ev, AI | 1 |
Panayotakopoulos, GD | 1 |
Day, S | 1 |
Peters, BS | 1 |
Kulasegaram, R | 1 |
Hoffmann, C | 1 |
Wolf, E | 1 |
Wyen, C | 1 |
Fätkenheuer, G | 1 |
Van Lunzen, J | 1 |
Stellbrink, HJ | 1 |
Stoehr, A | 1 |
Plettenberg, A | 1 |
Jaeger, H | 1 |
Noppeney, R | 1 |
Hentrich, M | 1 |
Goekbuget, N | 1 |
Hoelzer, D | 2 |
Horst, HA | 1 |
Shimomura, A | 1 |
Lilienfeld-Toal, Mv | 1 |
Balta, Z | 1 |
Schroers, E | 1 |
Schmidt-Wolf, IG | 1 |
Büttner, R | 1 |
Rücker, Av | 1 |
Gütgemann, I | 1 |
López, G | 1 |
Marcilla, F | 1 |
Ramos, C | 1 |
Arazo, P | 1 |
Lowenthal, RM | 1 |
Funnell, CF | 1 |
Hope, DM | 1 |
Stewart, IG | 1 |
Humphrey, DC | 1 |
Janus, C | 1 |
Edwards, BK | 1 |
Sariban, E | 1 |
Magrath, IT | 3 |
Reiter, A | 2 |
Toogood, IR | 1 |
Tiedemann, K | 1 |
Stevens, M | 1 |
Smith, PJ | 1 |
Tosi, P | 1 |
Visani, G | 1 |
Ottaviani, E | 1 |
Manfroi, S | 1 |
Tura, S | 1 |
Ito, C | 1 |
Evans, WE | 1 |
McNinch, L | 1 |
Coustan-Smith, E | 1 |
Mahmoud, H | 1 |
Pui, CH | 1 |
Campana, D | 1 |
Hunt, BJ | 1 |
Thomas, JA | 2 |
Burke, M | 2 |
Walker, H | 1 |
Yacoub, M | 1 |
Crawford, DH | 1 |
Geissler, RG | 1 |
Bergmann, L | 1 |
Hacker, H | 1 |
Knupp, B | 1 |
Walker, B | 1 |
Creatsas, GK | 1 |
Hassan, EA | 1 |
Deligeoroglou, EK | 1 |
Markaki, SG | 1 |
Michalas, SP | 1 |
Au Eong, KG | 1 |
Choo, CT | 1 |
Tsurusawa, M | 1 |
Katano, N | 1 |
Hirota, T | 1 |
Ito, M | 1 |
Yanase, T | 1 |
Asami, K | 1 |
Koizumi, S | 1 |
Nakayama, M | 1 |
Miyawaki, T | 1 |
Suzumiya, J | 1 |
Nishikawa, K | 1 |
Mugisima, H | 1 |
Horikoshi, Y | 1 |
Hatae, Y | 1 |
Iwai, A | 1 |
Anami, K | 1 |
Kikuchi, M | 1 |
Osima, K | 1 |
Kaneko, Y | 1 |
Kataoka, S | 1 |
Tanaka, A | 1 |
Chin, M | 1 |
Taga, T | 1 |
Watanabe, A | 1 |
Fujimoto, T | 1 |
Tweddle, DA | 1 |
Gennery, AR | 1 |
Reid, MM | 1 |
Hamilton, JR | 1 |
Windebank, KP | 1 |
Jung, DY | 1 |
Kim, JW | 1 |
Lee, SK | 1 |
Lee, WW | 1 |
Schrappe, M | 2 |
Tiemann, M | 1 |
Ludwig, WD | 2 |
Yakisan, E | 1 |
Zimmermann, M | 1 |
Mann, G | 1 |
Chott, A | 1 |
Ebell, W | 1 |
Klingebiel, T | 1 |
Graf, N | 1 |
Kremens, B | 1 |
Müller-Weihrich, S | 1 |
Plüss, HJ | 1 |
Zintl, F | 1 |
Henze, G | 1 |
Riehm, H | 1 |
Bassan, R | 1 |
Pogliani, E | 1 |
Lerede, T | 1 |
Fabris, P | 1 |
Rossi, G | 1 |
Morandi, S | 1 |
Casula, P | 1 |
Lambertenghi-Deliliers, G | 1 |
Vespignani, M | 1 |
Izzi, T | 1 |
Coser, P | 1 |
Corneo, G | 1 |
Barbui, T | 1 |
Wuchter, C | 1 |
Karawajew, L | 1 |
Ruppert, V | 1 |
Harbott, J | 1 |
Ratei, R | 1 |
Dörken, B | 1 |
Tzortzatou-Stathopoulou, F | 1 |
Papadopoulou, AL | 1 |
Moschovi, M | 1 |
Botsonis, A | 1 |
Tsangaris, GT | 1 |
Tankhiwale, SR | 1 |
Holey, MP | 1 |
Yelke, BS | 1 |
Raut, WK | 1 |
Bobhate, SK | 1 |
Bird, CC | 1 |
Waddell, AW | 2 |
Robertson, AM | 1 |
Currie, AR | 2 |
Steel, CM | 1 |
Evans, J | 1 |
Schief, A | 1 |
Adolf, GR | 1 |
Swetly, P | 1 |
Ziegler, JL | 2 |
Deisseroth, AB | 1 |
Glaubiger, DL | 1 |
Kent, HC | 1 |
Pizzo, PA | 1 |
Poplack, DG | 1 |
Levine, AS | 1 |
Andersson, J | 1 |
Ernberg, I | 1 |
Hiraiwa, A | 1 |
Yoshikawa, S | 1 |
Sao, H | 1 |
Yamauchi, T | 1 |
Minami, S | 1 |
Yoshikawa, H | 1 |
Kodera, Y | 1 |
Akao, Y | 1 |
Naito, K | 1 |
Yamada, K | 1 |
Pees, HW | 1 |
Riehm, HJ | 1 |
Schwamborn, J | 1 |
Malacarne, P | 1 |
Castaldi, G | 1 |
Miller, G | 1 |
Coope, D | 1 |
Mugerwa, J | 1 |
Bailey, I | 1 |
Olweny, C | 1 |
Kiryabwire, Y | 1 |
Garwicz, S | 1 |
Landberg, T | 1 |
Akerman, M | 1 |
Ravina, A | 1 |
Hirshaut, Y | 1 |
Weiss, GH | 1 |
Perry, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)[NCT00388193] | Phase 2 | 20 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
Treatment Regimen or Children or Adolescent With Mature B-cell NHL or B-AL in China[NCT02405676] | Phase 2/Phase 3 | 200 participants (Anticipated) | Interventional | 2015-01-31 | Active, not recruiting | ||
Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.[NCT05049473] | Phase 2 | 100 participants (Anticipated) | Interventional | 2014-01-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 reviews available for prednisolone and African Lymphoma
Article | Year |
---|---|
Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabin | 2020 |
Primary adrenal lymphoma presenting as Addison's disease: case report and review of the literature.
Topics: Addison Disease; Adrenal Cortex Neoplasms; Aged; Aged, 80 and over; Antineoplastic Combined Chemothe | 2004 |
Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 1994 |
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow T | 2001 |
Management of Epstein-Barr virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Burkitt Lymphoma; Clinical Trials as Topic; Female; H | 1988 |
[Burkitt's lymphoma and acute leukemias].
Topics: Acute Disease; Animals; Asparaginase; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Dactino | 1969 |
6 trials available for prednisolone and African Lymphoma
Article | Year |
---|---|
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; | 2010 |
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burki | 1993 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkyla | 1998 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinic
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymph | 1999 |
Management of Epstein-Barr virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Burkitt Lymphoma; Clinical Trials as Topic; Female; H | 1988 |
37 other studies available for prednisolone and African Lymphoma
Article | Year |
---|---|
Generalized lymphadenopathy: an unusual presentation of burkitt lymphoma in a Nigerian child: a case report.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; | 2019 |
Intravascular large B-cell lymphoma presenting as a pituitary mass with bilateral adrenal enlargement and haemophagocytic lymphohistiocytosis.
Topics: Adolescent; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphom | 2018 |
Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 2018 |
Burkitt Lymphoma Preceded by Autoimmune Hemolytic Anemia due to Anti-D Antibody.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Burkitt Lymphoma; Female; Humans; Prednisolone; Rho(D) Immune G | 2016 |
Prognostic significance of biochemical markers in African Burkitt's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Burkitt Lymphoma; Child; Chi | 2011 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Presch | 2003 |
In vitro resistance of leukaemic blasts to prednisolone in bcr-abl positive childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Burkitt Lymphoma; Child; Child, Preschool; Cytotoxicity | 2002 |
[Treatment of adult Berkitt-like lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; C | 2005 |
Severe osteoporosis and multiple fractures in an AIDS patient treated with short-term steroids for lymphoma: a need for guidelines.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Burkitt Lymphoma; Fractures, Comp | 2006 |
AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkit | 2006 |
Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; B-Lymphocytes | 2008 |
[Association between meningeal Burkitt lymphoma and Epstein-Barr virus in an HIV-infected patient].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymph | 2007 |
Normal infant after combination chemotherapy including teniposide for Burkitt's lymphoma in pregnancy.
Topics: Adult; Antineoplastic Agents; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Drug Thera | 1982 |
Surgical resection and limited chemotherapy for abdominal undifferentiated lymphomas.
Topics: Abdominal Neoplasms; Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bu | 1984 |
In vitro culture with prednisolone increases BCL-2 protein expression in adult acute lymphoblastic leukemia cells.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Asparaginase; Bo | 1996 |
Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Apoptosis; Bone Marrow Cells; Burkitt Lymphoma; Child; | 1996 |
Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosp | 1996 |
Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain; Burkitt Lymphoma; Central Nervous | 1997 |
Non-Hodgkin's ovarian lymphoma during adolescence: report of two cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Combined Mo | 1997 |
Burkitt lymphoma manifesting as acute proptosis.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Cycl | 1997 |
Posttransplantation B lymphoblastic leukemia with Burkitt-like features.
Topics: Administration, Oral; Biopsy; Bone Marrow; Burkitt Lymphoma; Child, Preschool; Cytomegalovirus Infec | 1999 |
Epstein-Barr virus-associated lymphoproliferative skin lesion with recurrent necrotic papulovesicles of the face.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Burkitt Lymphoma; Facial Dermatoses; Herpesvirus 4, Human; | 1999 |
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2000 |
Burkitt's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxo | 2002 |
Cytoplasmic receptor levels and glucocorticoid response in human lymphoblastoid cell lines.
Topics: Burkitt Lymphoma; Cell Line; Cell Survival; Cytoplasm; Humans; Leukemia; Leukemia, Lymphoid; Lymphom | 1975 |
[Lymphoblastomic sarcoma of the Burkitt type (the so-called "white Burkitt tumor") (author's transl)].
Topics: Adolescent; Antibodies; Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Herpesvirus 4, Hu | 1976 |
Glucocorticoid hormones inhibit DNA synthesis and enhance interferon production in human lymphoid cell line.
Topics: Burkitt Lymphoma; Cell Division; Cell Line; Dexamethasone; DNA; Dose-Response Relationship, Drug; Gl | 1979 |
A comparison of the effects of prednisolone and methylprednisolone on human lymphoblastoid cells.
Topics: Burkitt Lymphoma; Cell Line; Cell Survival; Humans; Leukemia; Lymphocytes; Methylprednisolone; Predn | 1977 |
Combined modality treatment of Burkitt's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Burkitt Lymphoma; Central Nervous System Diseases; Child; | 1978 |
Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience.
Topics: Adolescent; Adult; Africa; Age Factors; Antineoplastic Agents; Burkitt Lymphoma; Child; Child, Presc | 1977 |
[A successful case of Burkitt's lymphoma treated with allogeneic bone marrow transplantation].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lym | 1986 |
Effective treatment of lymphomas of Burkitt's type and B-ALL in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Burkitt Lymphoma; | 1985 |
["Starry sky' aspect of the thymus gland following the use of lympholytic drugs].
Topics: Animals; Burkitt Lymphoma; Mice; Niacinamide; Phagocytosis; Prednisolone; Thymus Gland; Triethylenem | 1972 |
Epstein-Barr viral nuclear antigen (EBNA) in tumor cell imprints of experimental lymphoma of marmosets.
Topics: Animals; Antigens, Viral; Azathioprine; Burkitt Lymphoma; Cell Line; Cell Nucleus; Cell Transformati | 1974 |
Intracerebral Burkitt's lymphoma: pathology, clinical features and treatment.
Topics: Adolescent; Allopurinol; Brain Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamid | 1974 |
Malignant lymphomas in children. A clinico-pathologic retrospective study. II. Non-Hodgkin's lymphomas.
Topics: Adolescent; Bone Marrow Diseases; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Femal | 1974 |
The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents.
Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Culture Techniques; Humans; Leukemia; Leukemia L12 | 1969 |